Author

Rivani Shah

University College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Courtney HimsworthiD· 2 shared Henrike P. MulleriD· 2 shared Jan J. MolenaariD· 2 shared John AndersoniD· 2 shared Judith WienkeiD· 2 shared Marta BarisaiD· 2 shared Ailsa Greppi· 1 shared Alice VitaliiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Courtney HimsworthORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringNature CommunicationsPeer-reviewedAug 5, 2025

Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function

Marta Barisa, Henrike P. Muller, Elisa Zappa…·John Anderson

The paper evaluates how the functional avidity of anti-B7H3 CAR-T constructs relates to their ability to trigger effector function against tumors with varying antigen density.

29 citationstop 1%

humanflow cytometry

𝕏 PostBluesky

Cancer BiologyEuropean Journal of CancerPeer-reviewedJan 27, 2025

Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma

Josephine G. M. Strijker, Guillem Pascual‐Pasto, Grant P. Grothusen…·Judith Wienke

This study identifies MIF as a key immunosuppressive factor in neuroblastoma that inhibits CAR T-cell efficacy, showing that blocking MIF enhances T-cell activation and therapeutic potential.

25 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky